Which Institutions Own Shares In Mereo Biopharma Group Plc ADR (MREO)?

Mereo Biopharma Group Plc ADR (NASDAQ: MREO) is 74.03% higher on its value in year-to-date trading and has touched a low of $0.69 and a high of $4.36 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MREO stock was last observed hovering at around $3.87 in the last trading session, with the day’s gains setting it 0.15%.

Currently trading at $4.02, the stock is 16.18% and 49.63% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing 3.88% at the moment leaves the stock 131.95% off its SMA200. MREO registered 337.19% gain for a year compared to 6-month gain of 216.54%. The firm has a 50-day simple moving average (SMA 50) of $73.09 and a 200-day simple moving average (SMA200) of -$21.28.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


Sponsored

The stock witnessed a 48.89% loss in the last 1 month and extending the period to 3 months gives it a 84.83%, and is 1.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.20% over the week and 10.61% over the month.

Mereo Biopharma Group Plc ADR (MREO) has around 36 employees, a market worth around $516.13M and $8.79M in sales. Profit margin for the company is -355.64%. Distance from 52-week low is 484.30% and -7.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-39.42%).

Mereo Biopharma Group Plc ADR quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to grow by 33.99% this year

65 institutions hold shares in Mereo Biopharma Group Plc ADR (MREO), with institutional investors hold 60.70% of the company’s shares. The shares outstanding are 128.39M, and float is at 128.39M with Short Float at 1.09%. Institutions hold 60.39% of the Float.

The top institutional shareholder in the company is Rubric Capital Management LP with over 11.62 million shares valued at $15.33 million. The investor’s holdings represent 17.15% of the MREO Shares outstanding. As of Jun 29, 2023, the second largest holder is Suvretta Capital Management, LLC with 7.36 million shares valued at $9.72 million to account for 10.87% of the shares outstanding. The other top investors are Rock Springs Capital Management, LP which holds 7.04 million shares representing 10.40% and valued at over $9.3 million, while Mangrove Partners holds 8.17% of the shares totaling 5.53 million with a market value of $7.3 million.